<code id='188D4583D4'></code><style id='188D4583D4'></style>
    • <acronym id='188D4583D4'></acronym>
      <center id='188D4583D4'><center id='188D4583D4'><tfoot id='188D4583D4'></tfoot></center><abbr id='188D4583D4'><dir id='188D4583D4'><tfoot id='188D4583D4'></tfoot><noframes id='188D4583D4'>

    • <optgroup id='188D4583D4'><strike id='188D4583D4'><sup id='188D4583D4'></sup></strike><code id='188D4583D4'></code></optgroup>
        1. <b id='188D4583D4'><label id='188D4583D4'><select id='188D4583D4'><dt id='188D4583D4'><span id='188D4583D4'></span></dt></select></label></b><u id='188D4583D4'></u>
          <i id='188D4583D4'><strike id='188D4583D4'><tt id='188D4583D4'><pre id='188D4583D4'></pre></tt></strike></i>

          
          WSS
          Portrait of Steve Quake wearing a blue shirt. -- biotech coverage from STAT
          Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

          SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

          Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.”  The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

          advertisement

          STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          comprehensive